Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As you probably know, iAbra is the key to revenues from Virolens. According to medicaldevice-network, other partners are also involved. One of which is Key Options. Basically, KeyOptions provides data driven service and has secured the rights to bring Virolens testing units to Australia, Latin America, Turkey and SE Asia. The link in the KeyOptions website to virolens is set as a holding page at the moment.
It might be that news is imminent that is currently under embargo
The optimst in me relies on being a simpleon. And while I can see all sorts of technical reasons not to invest in TTG froma short terj perspective a the moment, momentum from the longer term puts this as a very solid hold.
The tipping point IMO is where we are right now. The shares have tried to close above 250p for a few days now but just fail each time. However, it is not for want of tries. There is a niggling doubt that orders are not going to happen which is providing the limited upside, but the support for downside because there are plenty of other revenue streams.
I prefer to average up these days so have a little dry powder. The longer the wait for the company to win orders, the greater the potential for drift in the share price. I am actually rather more inclined to reduce my holding and bank profits than to invrease exposure to unnecessary short term risk. Continued delay will only increase volatility.
I fear there is wild activity ahead.
Still so many AT ALGO trades.
https://api.londonstockexchange.com/api/gw/lse/download/TTG/trades
Thought we’d have had some orders for Virolens by now given MHRA approval and Scotland approval news.
They have said most orders are likely to be international but no update yet from iAbra.
Meanwhile TTG is ticking up nicely of its own steam. We just need to hold above 250 resistance to extend that rising trend to ATH around 290.
The 50DMA is above the support, lower turquoise line.
All looks very bullish on its own. Bring on some news!
https://www.marketscreener.com/quote/stock/TT-ELECTRONICS-PLC-4002367/charts/
Trek
Bullettin boards have a nasty habit of attracting highly focussed remarks which have a sense of urgency. Of patticular concern to me are those that claim to have very substantial holdings and are following every nunce, twist and turnin the share price and claim that they are investors not traders and are not concerned about being underwater as their focus is on the long term.
More often than not, I will use the filter facility specifically on those that take this line. It is clear to me that they are worried about their exposure to the instrument involved and rely on the psychology that applause to their comtribution will mean that all will be well. Often these same person will claim market manipulation, short attack or some other unsubstantiated element to justify frustration.
I think that there has been just one occasion when I moved the market in an equity. It was a very lightly traded stock and i had “fat finger syndrome”. I placed a buy order for £10,000 shares and totally unknown to me at the time the NMS (normal market size) was £2,500. This was based on the average bargain executed over a rolling 3 month period. Now, £10,000 is not exactly big beans, but it was over 3x NMS so triggered an automatic 1 hour delay in reporting. (I did not know that at the time), but the market makers got a little excited. The share price began hopping around and in turn it triggered a flurry of bargains including trades between brokers. These are uncommon these days. The price moved up 0.75% and never fell back. Co-incidence, IMO as private investors tend to fizzle out when executing single bargains greater than £250k. The real movers are news and fund managers. Sadly with the proliferation of algorithmic bargains, fund managers can disguise their tracks.
I doubt that I could move any equity with a bargain of that size these days.
The strategy therefore is to ignore the loudest voices on BB’s and certainly ignore those that appear desperate and bang on about the benefit of a long term view.or that the market makers will not prise a share from their hands until it reaches £xyz.
The wise can learn more from a fool than a fool from the wise. I have much to learn.
Also 2 mins per test, allthough that sounds v fast, is considerably longer than 20 secs for Virolens, which would make a big difference in a mass testing scenario...
"Each disposable test cartridge contains multiple sensors and a unique QR code which is linked to the user's cell phone or another connected device. "
How much will these disposable cartridges cost with multiple sensors??? Multiply by thousands per week? I do think they will be more suitable for small numbers, however Virolens will probably be far cheaper per test.
MM’s must have posted a scheme. As soon as it gets close the 2.50 the AT ALGO trades step up.
https://api.londonstockexchange.com/api/gw/lse/download/TTG/trades
Trek
To sell when the risk of owning shares has increased and it no longer benefits me. There is no advantage in setting a price as I have learned to run my profits. The sectors that have the greatest potential in the years ahead are renewables, healthcare and technology IMO so over the last 3-4 years have been skewing my portfolio in those directions.
Other sectors have short term influence that I expect to do very well so will use Investment Trusts to enjoy any uplift. UK as a market since 2016 Brexit announcement has been avoided by international investors. Press reports and influential commentators such as the Bank of England Chief Economist are talking up the prospects. Thus adding to my holdings in THRG and MTU.
Not, of course advice, simply my thought process and execution of decisions that I am making. My ISA and that for my wife are managed for me. I look after our SIPPS, tiny dealing accounts to which monthly savings are added and the acounts for my children.
My financial target is simply to beat the market. Sometimes it is beaten by a wide margin and others not so. I am improving where for the first 20 years averaged 8%, years 10 to 30 had improved to 12%, 20 to 30 improved slighly to 12.5% and now is running very well indeed with the best years having gains of over 20%. This has brought my long term (42 yr) average to 13.6%
What’s your target Alas?
If it is similar to Virolens, that is probably very good news despite potentially as a rival to TTG. My thought process is that active air crew in service should have different tests from passengers and in using similar, though, I assume with different patent protection for the IP thus endorsing the use of rapid screening and minimally invasive.
https://www.prnewswire.com/news-releases/canarys-25-second-98-sensitivity-digital-covid-19-saliva-test-achieves-ce-mark-301246811.html
BA trialling it with crew
This has been endorsed with a buy note from RBC issued today - target increased from 280p to 290p.
Obviously the trading update is for past 3 months, so very little trades done regarding Virolens (financially) what we want to know is the orders for this machine and the value of those orders. I have no doubt that question will be asked today.
Absolutely bizarre. Let’s hope they answer some of the questions sent to them regarding Virolens in the AGM today.
On a day like today ill take it. Growth looks positive and plenty of confidence.
Cautious outlook, not a squeak about Virolens. Not have I received quote from any of the three companies involved that I requested 2 months ago. A little odd.
I wonder if they’ll announce the orders in the annual trading statement on Thursday as they’re not going to RNS every order coming in. Big day Thursday imo. Fingers crossed.
https://www.hartlepoolmail.co.uk/business/hartlepool-electronics-firm-set-to-create-100-new-jobs-as-it-steps-up-production-of-groundbreaking-covid-19-testing-machine-3221063
£4 million investment and double workforce from 100 to 200 to manufacture Virolens covid test machines, the orders must be phenomenal!!!
visit from from chancellor.
Chancellor Sunak said: “I was delighted to visit TT Electronics to see the excellent work they are doing, particularly on the Covid-19 testing device, Virolens.”
you can bet the government will be waving the British flag at this achievement....hopefully along with some big orders.
recent Berenberg price prediction of 285p does not include virolens!!! I really do expect this share price to double over the next 12 months.
....with overweight note
It can be disheartening when share prices appear to be falling, yet the broader sentiment is optimistic. This week has been quite a good example (well, for me and my investments, anyway) where we learn that the UK is most certainly re-starting business and removing many of the obstacles and restrictions to liberty.
The upbeat message to expect one of the highest growth rates in 70 years has not yet translated to share prices in those quoted companies that should be the great companies in the future - hydrogen fuel cell, battery energy, renewables etc. Actually these (in my portfolio) have been the worst performers for the last month.
Time in the market will usually benefit investors. After all, the research to pick the wheat from the chaff for growth companies (and TTG is one IMO) means that news to propel a share price is outside control and will happen when it happens. Trying to time for this is unrealistic and adds a layer of insecurity that need not be present. While it may be disheartening in the short term canny investors tend to have long horizons and desire substantial rewards for patience.
oogleflugal, we MIGHT just hear something in the coming weeks. There is a sense of frustration that although the rollout of vaccine has been conducted at pace in the UK, we are not able to live our drab lives as we did, pre pandemic and that other countries do not share the same progress. The hint of relaxation of rules from late June is great for the UK, but for those wishing to travel there needs to be an effective, minimally intrusive, swift and in-expensive test at the point of departure/arrival for the period that brings all nations onto a level playing field.
It will start with domestic and very short haul (90 min duration) flights, I suspect with Dublin, Munich, Brussels, Paris and Amsterdam as the limit of travel from ANY UK airport. Since the principal ones are, Heathrow, Gatwick, Birmingham, Manchester, Newcastle, Liverpool, Luton, Bristol and Edinburgh, (many others of course), it would not be unreasonable to have 10 points of test in each airport at the point where x-ray screening is made and , by the time that hand luggage has been scanned and passengers are through the control gates, the results will have been processed and a physical stamp provided on a boarding pass. That SHOULD provide the outbound permission for entry to foreign soil and a similar arrangement for testing in the arrivals system before passport control for a similar stamping.
I'd like release of RNS to confirm deployment (co-incidental with Government announcement) of a TTG solution for travel arrangements as people return to normal life. On the assumption that TTG are going to benefit from their expertise the window to buy at present prices is shortening. I foresee increasing volatility in the short term and am not at all confident that announcement is imminent.
It should have been Rishi. Anyway top question to city of London 'Why haven't we heard of Virolens before?' andIs Virolens for real?
The answer to this one is very simple…YES. It’s easy to be skeptical when faced with a technology that seems almost too good to be true. We understand the skepticism but we already have Virolens installed at our first screening centre in the City of London, with the capacity to test 800 individuals an hour. It is very much real and providing quick and accurate Covid test results.
I expect he wants to see how well his/our money has been spent compared to other scams that have been going on. Interesting article talks about already being in use in other countries. As far as I know UK was the first to give its approval. The market is being a bit slow to latch on to this, I expect it will rerate on next update. If they are scaling up the Hartlepool manufacturing site they must have some order figures by now.
and yet no SP movement. Why is TTG unloved?